mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.065 |
0.3 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |